• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的中心凹和周边区效果:一项队列研究。

Foveal and Extrafoveal Effects of Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Cohort Study.

机构信息

Ophthalmology Department, Hospital De Braga, Braga, Portugal.

Ophthalmology Department, Hospital Lusíadas, Porto, Portugal.

出版信息

Semin Ophthalmol. 2022 Feb 17;37(2):153-157. doi: 10.1080/08820538.2021.1931357. Epub 2021 May 23.

DOI:10.1080/08820538.2021.1931357
PMID:34027797
Abstract

PURPOSE

To compare the efficacy and safety of foveal and extrafoveal half-dose photodynamic therapy (HD-PDT) for chronic Central Serous Chorioretinopathy (cCSC).

METHODS

This retrospective, cohort study included cCSC eyes submitted to HD-PDT on foveal (F) or extrafoveal (E) areas. Patients were evaluated at baseline and 12 weeks after treatment for best corrected visual acuity (BCVA) and the following spectral-domain optical coherence tomography (SD-OCT) subfoveal parameters: central macular thickness (CMT), outer nuclear layer, external limiting membrane, ellipsoid zone, interdigitation zone, choroidal thickness and subretinal fluid (SRF).

RESULTS

F group comprised 33 eyes (47.1%) and E group comprised 37 eyes (52.9%). Both groups showed an improvement of BCVA after HD-PDT with no significant differences in final BCVA ( = .41). CMT and SRF showed a significant improvement after HD-PDT in both groups, but the rate of disruption of the external retinal layers remained stable. During follow-up, SD-OCT parameters and the rate of anatomical success showed no significant differences regarding the treatment location. No major sequelae were noticed.

CONCLUSION

Foveal and extrafoveal applications of HD-PDT for cCSC showed comparable efficacy and safety.

摘要

目的

比较黄斑中心凹和中心凹外半剂量光动力疗法(HD-PDT)治疗慢性中心性浆液性脉络膜视网膜病变(cCSC)的疗效和安全性。

方法

这是一项回顾性队列研究,纳入了接受 HD-PDT 治疗的 cCSC 眼,治疗部位为黄斑中心凹(F)或中心凹外(E)区域。治疗后 12 周,对患者进行最佳矫正视力(BCVA)和以下频域光相干断层扫描(SD-OCT)亚区参数评估:中心黄斑厚度(CMT)、外核层、外界膜、椭圆体带、外丛状层、脉络膜厚度和视网膜下液(SRF)。

结果

F 组包括 33 只眼(47.1%),E 组包括 37 只眼(52.9%)。两组患者在 HD-PDT 后均有 BCVA 改善,最终 BCVA 无显著差异( =.41)。CMT 和 SRF 在两组患者中均在 HD-PDT 后得到显著改善,但外视网膜层的破坏率保持稳定。在随访期间,SD-OCT 参数和解剖学成功率在治疗部位方面没有显著差异。未发现明显的后遗症。

结论

cCSC 的黄斑中心凹和中心凹外应用 HD-PDT 具有相似的疗效和安全性。

相似文献

1
Foveal and Extrafoveal Effects of Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Cohort Study.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的中心凹和周边区效果:一项队列研究。
Semin Ophthalmol. 2022 Feb 17;37(2):153-157. doi: 10.1080/08820538.2021.1931357. Epub 2021 May 23.
2
Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.光动力疗法治疗黄斑中心凹外有视网膜下液的慢性中心性浆液性脉络膜视网膜病变。
Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):2029-2035. doi: 10.1007/s00417-017-3720-z. Epub 2017 Jul 3.
3
Comparison of visual and anatomical outcomes of half-fluence and half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变患者中半光通量与半剂量光动力疗法的视觉和解剖学结果比较
Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2063-73. doi: 10.1007/s00417-014-2926-6. Epub 2015 Jan 24.
4
Morphological integrity of the outer retinal layers and visual prognosis in chronic central serous chorioretinopathy after half-dose photodynamic therapy: a qualitative SD-OCT analysis.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变后外层视网膜形态完整性与视力预后的定性 SD-OCT 分析。
Lasers Med Sci. 2022 Dec 21;38(1):9. doi: 10.1007/s10103-022-03676-z.
5
Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy.中浆患者接受半剂量光动力疗法后的长期外层视网膜改变。
Photodiagnosis Photodyn Ther. 2021 Jun;34:102235. doi: 10.1016/j.pdpdt.2021.102235. Epub 2021 Feb 22.
6
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy.半剂量光动力疗法治疗伴有中心凹受累萎缩的慢性中心性浆液性脉络膜视网膜病变的疗效。
Graefes Arch Clin Exp Ophthalmol. 2021 Apr;259(4):905-910. doi: 10.1007/s00417-020-04959-3. Epub 2020 Oct 29.
7
Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变。
Retina. 2013 Feb;33(2):316-23. doi: 10.1097/IAE.0b013e318280769c.
8
Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy.荧光素血管造影引导与吲哚菁绿血管造影引导半时光动力疗法治疗中心性浆液性脉络膜视网膜病变的疗效比较。
Photodiagnosis Photodyn Ther. 2020 Sep;31:101955. doi: 10.1016/j.pdpdt.2020.101955. Epub 2020 Aug 18.
9
Microperimetric changes and fixation stability status after half-dose photodynamic therapy for chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变半剂量光动力治疗后的微视野变化及固视稳定性状态
Eur J Ophthalmol. 2020 Sep;30(5):1053-1060. doi: 10.1177/1120672119858877. Epub 2019 Jul 1.
10
Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.特发性中心性浆液性脉络膜视网膜病变患者接受黄斑外光动力疗法治疗后脉络膜厚度的变化。
Acta Ophthalmol. 2012 Dec;90(8):738-43. doi: 10.1111/j.1755-3768.2011.02157.x. Epub 2011 May 17.